Cover Image

Extracorporal shock wave therapy enhances receptor for advanced glycated end-product-dependent flap survival and angiogenesis

Background/ObjectivesLoss of skin flaps due to deteriorated wound healing is a crucial clinical issue. Extracorporal shock wave therapy (ESWT) promotes flap healing by inducing angiogenesis and suppressing inflammation. The receptor for advanced glycation end-products (RAGEs) was identified to play

Saved in:
Bibliographic Details
Main Authors: Birgin, Emrullah (Author) , Gebhardt, Christoffer (Author) , Hetjens, Svetlana (Author) , Fischer, Sebastian (Author) , Rückert, Felix (Author) , Reichenberger, Matthias (Author)
Format: Article (Journal)
Language:English
Published: April 2018
In: Annals of plastic surgery
Year: 2018, Volume: 80, Issue: 4, Pages: 424-431
ISSN:1536-3708
DOI:10.1097/SAP.0000000000001279
Online Access:Verlag, Volltext: https://doi.org/10.1097/SAP.0000000000001279
Get full text
Author Notes:Emrullah Birgin, Christoffer Gebhardt, Svetlana Hetjens, Sebastian Fischer, Felix Rückert, and Matthias Reichenberger
Description
Summary:Background/ObjectivesLoss of skin flaps due to deteriorated wound healing is a crucial clinical issue. Extracorporal shock wave therapy (ESWT) promotes flap healing by inducing angiogenesis and suppressing inflammation. The receptor for advanced glycation end-products (RAGEs) was identified to play
Item Description:Gesehen am 06.09.2019
Physical Description:Online Resource
ISSN:1536-3708
DOI:10.1097/SAP.0000000000001279

Similar Items